NEW YORK – CStone Pharmaceuticals said on Friday that it submitted a new drug application for its precision cancer drug avapritinib (Ayvakit) to the Taiwan Food and Drug Administration.
NEW YORK – CStone Pharmaceuticals said on Friday that it submitted a new drug application for its precision cancer drug avapritinib (Ayvakit) to the Taiwan Food and Drug Administration.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.